How the Inflation Reduction Act Could Impact Your Prescription Drug Costs
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Forty-eight million Americans use Medicare Part D to access their prescription medications, and according to a Department of Health and Human Services study from January of this year, more than 5 million Medicare beneficiaries are struggling to afford those prescriptions. But if enacted, the Inflation Reduction Act could soon bring those prices down. The legislation would give the federal government more bargaining power in Medicare negotiations with pharmaceutical companies and cap out-of-pocket spending on prescription drugs for covered Medicare recipients beginning in 2025. We’ll talk about the bill and how it could impact your prescription drug costs.
Guests:
Juliette Cubanski, deputy director of the Program on Medicare Policy, KFF (Kaiser Family Foundation).
Astrid Galván, editor, Axios Latino.
David Mitchell, founder, Patients For Affordable Drugs, Patients For Affordable Drugs NOW - diagnosed with multiple myeloma in 2010.
Learn more about your ad choices. Visit megaphone.fm/adchoices